English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Hong Kong International Optical Fair opens in November
Oct 18, 2019 20:00 HKT
Cheney Mao - Chairman & CEO, Viva Biotech, China
Oct 14, 2019 16:38 HKT
首家赴港台資創辦生技公司--東曜藥業掌握國際資源 打造藥企新契機
Oct 09, 2019 09:04 HKT
坐拥产品首发优势登陆IPO 复宏汉霖成年内生物科技第一股
Sep 25, 2019 12:26 HKT
坐擁產品首發優勢登陸IPO 復宏漢霖成年內生物科技第一股
Sep 25, 2019 12:24 HKT
破冰股复宏汉霖首日挂牌 步入商业化获利可期
Sep 25, 2019 12:18 HKT
破冰股復宏漢霖首日掛牌 步入商業化獲利可期
Sep 25, 2019 12:17 HKT
复宏汉霖产线后续力量充沛 全球商业布局抢占市场份额
Sep 16, 2019 17:43 HKT
復宏漢霖產線後續力量充沛 全球商業佈局搶佔市場份額
Sep 16, 2019 17:42 HKT
多款单抗产品「收获期」将至 复宏汉霖剑指海外拓展商机
Sep 12, 2019 10:43 HKT
多款單抗產品「收穫期」將至 復宏漢霖劍指海外拓展商機
Sep 12, 2019 10:42 HKT
知臨集團已啟動用於治療包括MRSA的金黃色葡萄球菌感染小分子候選藥物ALS-4的IND籌備研究
Sep 10, 2019 13:02 HKT
Aptorum Group has initiated IND-Enabling Studies for its ALS-4 Small Molecule Candidate for the Treatment of Infections Caused by Staphylococcus Aureus including MRSA
Sep 10, 2019 13:01 HKT
知臨集團宣布靶向肥胖症微生物組候選藥物和神經母細胞瘤再利用候選藥物的開發
Sep 10, 2019 12:37 HKT
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
Sep 10, 2019 12:36 HKT
中国生物制药公布2019年中期业绩
Aug 29, 2019 16:42 HKT
中國生物製藥公佈2019年中期業績
Aug 29, 2019 16:41 HKT
Sino Biopharmaceutical Announces 2019 Interim Results
Aug 29, 2019 16:40 HKT
Captiva Verde Land Corp signs Purchase Agreement for 5.6 mil sq.ft Outdoor Grow Land Package in New Brunswick, Canada; announces Private Placement to fund Cannabis Outdoor Grow Infrastructure Build Out
Jul 24, 2019 12:00 HKT
Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit
Jul 24, 2019 15:00 HKT
Next >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: